With the MDR sprint mercifully behind them, medtech firms must now turn their attention to the next leg of Europe’s revamped regulatory relay: the IVDR.
Combines Illumina’s decentralized installed base with Roche’s assay development to provide broad access to clinical oncology next-generation sequencing.